Joint Formulary & PAD

Chenodeoxycholic acid - Metabolic disorders

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Not Specified
Associated Icons :
BNF SPC
NHSE
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Chenodeoxycholic acid
Indication :
Metabolic disorders
Group Name :
Keywords :
Cerebrotendinous xanthomatosis, CTX
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Chenodeoxycholic acid is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Metabolic disorders.

Committee Recommendations (1)

This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care